脑小血管病与残余胆固醇的关系研究进展
Research Progress on the Relationship between Cerebral Small Vessel Disease and Remnant Cholesterol
摘要: 近年来,围绕脑小血管病危险因素及发病机制的临床和实验研究发现,仅仅控制低密度脂蛋白这一危险因素后仍有脑小血管病发生与进展的风险,近年来关于残余胆固醇的研究发现其是心血管疾病的剩余危险因素,且残余胆固醇也与急性缺血性脑卒中的发生与发展有一定关系,但国内对残余胆固醇与脑小血管病关系的研究相对匮乏。本综述旨在系统性地梳理和整合当前关于RC与CSVD关系的研究进展。本文首先详细阐述CSVD的传统及新兴危险因素,明确RC在其中的潜在定位。其次解析RC的生物学定义、介导动脉粥样硬化的病理生理机制。在此基础上,本综述的核心部分将重点分析RC在CSVD病理生理学中的多重作用,包括血管内皮功能障碍、血脑屏障破坏、神经炎症与氧化应激等等核心病理环节中的调控机制。并探讨RC水平与CSVD不同影像学亚型的关联性,并结合临床研究证据进行综合评述。最后,本文讨论RC作为CSVD防治新靶点的潜在价值、面临的挑战及未来的研究方向,以期为揭示CSVD的发病机制、开发新型干预策略提供科学依据与理论参考。
Abstract: In recent years, clinical and experimental studies on the risk factors and pathogenesis of cerebral small vessel disease (CSVD) have found that there is still a risk of the occurrence and progression of CSVD even after only controlling low-density lipoprotein, a single risk factor. Recent studies on remnant cholesterol (RC) have identified it as a remnant risk factor for cardiovascular diseases, and RC is also associated with the occurrence and development of acute ischemic stroke. However, domestic research on the relationship between RC and CSVD is relatively scarce. This review aims to systematically sort out and integrate the current research progress on the relationship between RC and CSVD. First, this article elaborates in detail on the traditional and emerging risk factors of CSVD, and clarifies the potential position of RC among them. Second, it deeply analyzes the definition and pathophysiological mechanisms of atherogenesis of RC. On this basis, the core part of this review will focus on analyzing the multiple roles of RC in the pathophysiology of CSVD, including key links such as vascular endothelial dysfunction, blood-brain barrier disruption, neuroinflammation, and oxidative stress. It also explores the correlation between RC levels and different imaging subtypes of CSVD, and conducts a comprehensive review combined with clinical research evidence. Finally, this article discusses the potential value, challenges, and future research directions of RC as a new target for the prevention and treatment of CSVD, providing a scientific basis and theoretical reference for revealing the pathogenesis of CSVD and developing new intervention strategies.
文章引用:杨育飞. 脑小血管病与残余胆固醇的关系研究进展[J]. 临床医学进展, 2026, 16(5): 2984-2992. https://doi.org/10.12677/acm.2026.1652112

参考文献

[1] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治指南2020 [J]. 中华神经科杂志, 2022, 55(8): 807-818.
[2] Dupré, N., Drieu, A. and Joutel, A. (2024) Pathophysiology of Cerebral Small Vessel Disease: A Journey through Recent Discoveries. Journal of Clinical Investigation, 134, e172841.
[3] Ren, B., Tan, L., Song, Y., et al. (20220 Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment. Frontiers in Neurology, 13, Article 843953.
[4] Zhang, W., Liu, H., Zhang, Y.L. and Wang, M.X. (2021) Research Advances in Risk Factors of Cognitive Disorder Caused by Cerebral Small Vessel Disease. Academic Journal of Chinese Pla Medical School, 42, 235-238.
[5] Hilal, S., Mok, V., Youn, Y.C., Wong, A., Ikram, M.K. and Chen, C.L. (2017) Prevalence, Risk Factors and Consequences of Cerebral Small Vessel Diseases: Data from Three Asian Countries. Journal of Neurology, Neurosurgery & Psychiatry, 88, 669-674. [Google Scholar] [CrossRef] [PubMed]
[6] Osman, A., Kanaan, A., Azeroual, S., Abubakr, M., et al. (2025) Hypertension and Cerebral Small Vessel Disease: A Review of the Pathophysiology, Progression, and Prevention. Cureus, 17, e92760.
[7] Taylor-Bateman, V., Gill, D., Georgakis, M.K., et al. (2022) Cardiovascular Risk Factors and MRI Markers of Cerebral Small Vessel Disease: A Mendelian Randomization Study. Neurology, 98, e343-e351.
[8] Liu, J., Pan, S., Wang, X., Liu, Z. and Zhang, Y. (2023) Role of Advanced Glycation End Products in Diabetic Vascular Injury: Molecular Mechanisms and Therapeutic Perspectives. European Journal of Medical Research, 28, Article No. 553. [Google Scholar] [CrossRef] [PubMed]
[9] Horton, W.B. and Barrett, E.J. (2020) Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocrine Reviews, 42, 29-55. [Google Scholar] [CrossRef] [PubMed]
[10] 苏岑, 靳彪, 夏海平, 等. 脑小血管病的影像总负荷评估及相关危险因素的研究[J]. 当代医学, 2022, 28(7): 14-17.
[11] Zhu, C.T. and Hu, W.L. (2022) Analysis on Risk Factors for Total Cerebral Small Vessel Disease Burden in Patients with Dizziness or Vertigo. Chinese Journal of Stroke, 17, 354-359.
[12] Jin, T., Yang, H., Liu, F., Lin, S., Hu, J., Wang, J., et al. (2026) Impact of APOE Ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients with Cerebral Small Vessel Disease. Annals of Clinical and Translational Neurology, 13, 430-441. [Google Scholar] [CrossRef
[13] Georgakis, M.K., Malik, R., Anderson, C.D., Parhofer, K.G., Hopewell, J.C. and Dichgans, M. (2020) Genetic Determinants of Blood Lipids and Cerebral Small Vessel Disease: Role of High-Density Lipoprotein Cholesterol. Brain, 143, 597-610. [Google Scholar] [CrossRef] [PubMed]
[14] 崔瑜, 张沐源, 孟清丽, 等. 血清同型半胱氨酸水平对脑小血管病总负荷的影响[J]. 中华保健医学杂志, 2024, 26(1): 42-44.
[15] Huang, S., Yin, L., Xu, Y., Zou, C. and Chen, L. (2016) The Homocysteine Associated Variant Rs548987 of SLC17A3 Confers Susceptibility to Ischemic Stroke in Chinese Population. Journal of the Neurological Sciences, 370, 78-81. [Google Scholar] [CrossRef] [PubMed]
[16] Low, A., Mak, E., Rowe, J.B., et al. (2019) Inflammation and Cerebral Small Vessel Disease: A Systematic Review. Ageing Research Reviews, 53, Article 100916.
[17] 于振江, 芦朋. 脑小血管病所致抑郁患者危险因素筛查及多模态影像学评估[J]. 中外医疗, 2022, 41(7): 31-35.
[18] Yang, Y., Qian, Y., Huang, J. and Luo, Y. (2026) Cerebral Small Vessel Disease and Blood-Brain Barrier Disruption: Mechanisms and Therapeutic Strategies in Cognitive Impairment. Translational Stroke Research, 17, Article No. 36. [Google Scholar] [CrossRef
[19] Hannawi, Y. (2024) Cerebral Small Vessel Disease: A Review of the Pathophysiological Mechanisms. Translational Stroke Research, 15, 1050-1069. [Google Scholar] [CrossRef] [PubMed]
[20] Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., et al. (2020) 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41, 111-188. [Google Scholar] [CrossRef] [PubMed]
[21] 黄本林, 王宁, 王妮, 冷丽, 朱星成. 估算法和测量法在血清残余脂蛋白胆固醇评估中的比较[J]. 临床检验杂志, 2022, 40(4): 257-261.
[22] Martin, S.S., Blaha, M.J., Elshazly, M.B., Brinton, E.A., Toth, P.P., McEvoy, J.W., et al. (2013) Friedewald-Estimated versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications. Journal of the American College of Cardiology, 62, 732-739. [Google Scholar] [CrossRef] [PubMed]
[23] Chen, J., Kuang, J., Tang, X., Mao, L., Guo, X., Luo, Q., et al. (2020) Comparison of Calculated Remnant Lipoprotein Cholesterol Levels with Levels Directly Measured by Nuclear Magnetic Resonance. Lipids in Health and Disease, 19, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
[24] Sandesara, P.B., Virani, S.S., Fazio, S. and Shapiro, M.D. (2018) The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine Reviews, 40, 537-557. [Google Scholar] [CrossRef] [PubMed]
[25] Björnson, E., Adiels, M., Gummesson, A., Taskinen, M., Burgess, S., Packard, C.J., et al. (2024) Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations with Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol. Journal of the American College of Cardiology, 84, 1328-1338. [Google Scholar] [CrossRef] [PubMed]
[26] Kaiser, Y., Daghem, M., Tzolos, E., Meah, M.N., Doris, M.K., Moss, A.J., et al. (2022) Association of Lipoprotein(a) with Atherosclerotic Plaque Progression. Journal of the American College of Cardiology, 79, 223-233. [Google Scholar] [CrossRef] [PubMed]
[27] Saeed, A., Feofanova, E.V., Yu, B., Sun, W., Virani, S.S., Nambi, V., et al. (2018) Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. Journal of the American College of Cardiology, 72, 156-169. [Google Scholar] [CrossRef] [PubMed]
[28] Castillo-Nunez, Y., Morales-Villegas, E. and Aguilar-Salinas, C.A. (2022) Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis. Revista de Investigación Clínica, 74, 61-70. [Google Scholar] [CrossRef] [PubMed]
[29] Aung, H.H., Lame, M.W., Gohil, K., An, C., Wilson, D.W. and Rutledge, J.C. (2013) Induction of ATF3 Gene Network by Triglyceride-Rich Lipoprotein Lipolysis Products Increases Vascular Apoptosis and Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 2088-2096. [Google Scholar] [CrossRef] [PubMed]
[30] Gao, Y., Li, D., Lin, J., Thomas, A.M., Miao, J., Chen, D., et al. (2022) Cerebral Small Vessel Disease: Pathological Mechanisms and Potential Therapeutic Targets. Frontiers in Aging Neuroscience, 14, Article 961661. [Google Scholar] [CrossRef] [PubMed]
[31] Zhou, W., Wang, T., Zhu, L., Shi, Y., Yu, C., Bao, H., et al. (2025) Associations of Body Mass Index and Remnant Cholesterol with Hyperuricemia in Patients with Hypertension. BMC Endocrine Disorders, 25, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
[32] Cyr, A.R., Huckaby, L.V., Shiva, S.S. and Zuckerbraun, B.S. (2020) Nitric Oxide and Endothelial Dysfunction. Critical Care Clinics, 36, 307-321. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, C., Fu, H., Xu, H., Yang, H., Min, X., Wu, W., et al. (2025) Non-Traditional Lipid Biomarkers in Atherosclerotic Cardiovascular Disease: Pathophysiological Mechanisms and Strategies to Address Residual Risk. Frontiers in Endocrinology, 16, Article 1576602. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, H., Zhang, C., Zhang, Y., Tian, T., Wang, T., Chen, J., et al. (2024) The Role of Residual Inflammatory Risk and LDL Cholesterol in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention. Journal of Clinical Lipidology, 18, e746-e755. [Google Scholar] [CrossRef] [PubMed]
[35] Inoue, Y., Shue, F., Bu, G. and Kanekiyo, T. (2023) Pathophysiology and Probable Etiology of Cerebral Small Vessel Disease in Vascular Dementia and Alzheimer’s Disease. Molecular Neurodegeneration, 18, Article No. 46. [Google Scholar] [CrossRef] [PubMed]
[36] Elías-López, D., Vedel-Krogh, S., Kobylecki, C.J., Wadström, B.N. and Nordestgaard, B.G. (2024) Impaired Renal Function with Higher Remnant Cholesterol Related to Risk of Atherosclerotic Cardiovascular Disease: A Cohort Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 44, 2647-2658. [Google Scholar] [CrossRef] [PubMed]
[37] Su, L.J., Zhang, J.H., Gomez, H., et al. (2019) Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxidative Medicine and Cellular Longevity, 2019, 1-13. [Google Scholar] [CrossRef] [PubMed]
[38] 刘彤彤, 张熙, 王枭冶, 方锐, 葛金文, 孟盼. 高血压和衰老为主要危险因素的脑小血管病动物模型的建立[J]. 中国实验动物学报, 2022, 30(7): 918-926.
[39] Kim, S., Jung, U.J. and Kim, S.R. (2024) Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases. Antioxidants, 13, Article 1462. [Google Scholar] [CrossRef] [PubMed]
[40] Moiz, B., Vargas, V.A., Brandon, K.D., Sangha, G., Weber, C., Li, A., et al. (2025) Cholesterol Depletion with U18666A and Methyl-β Cyclodextrin Increased Small Molecule Permeability across Brain Microvascular Endothelial Cells. Annals of Biomedical Engineering, 53, 3222-3236. [Google Scholar] [CrossRef
[41] 艾玥, 伏玉洁, 陈梦双, 等. 残余胆固醇与急性缺血性脑卒中发病相关性的研究[J]. 中国急救复苏与灾害医学杂志, 2022, 17(9): 1160-1163+1173.
[42] Li, S., Wang, Y., Yu, L., Gao, Y., Yang, Y., Zhu, H., et al. (2023) Association of Blood Lipid Profile Components with White Matter Hyperintensity Burden in Cerebral Small Vessel Disease. Current Neurovascular Research, 20, 175-182. [Google Scholar] [CrossRef] [PubMed]
[43] Rao, C., Zhu, L., Yu, C., Zhang, S., Zha, Z., Gu, T., et al. (2024) Association of Novel Lipid Indices with the White Matter Hyperintensities in Cerebral Small Vessel Disease: A Cross-Sectional Study. Lipids in Health and Disease, 23, Article No. 333. [Google Scholar] [CrossRef] [PubMed]
[44] 李晨. 单项血脂及其与HDL比值、ApoB/ApoA-1水平与脑微出血的相关性研究[D]: [硕士学位论文]. 开封: 河南大学, 2023.
[45] 侯燚辉. 残余胆固醇和常规脂质参数与脑小血管病发病相关性研究[D]: [硕士学位论文]. 承德: 承德医学院, 2024.
[46] 秦凡宜. 甘油三酯葡萄糖指数、残余胆固醇与脑小血管病总负荷的相关性研究[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2024.